Versatis® in PHN treatment guidelines
Clinical studies demonstrated efficacy of Versatis in patients with PHN. It is therefore recommended as a first-line treatment option for PHN by the European Federation of Neurological Societies (EFNS)6
In addition, the plaster provide a protective cover over the hypersensitive area of the skin and offers an immediate cooling and soothing effect. 2,8
First line treatment
Versatis® is recommended as first-line treatment for PHN in the elderly by the EFNS6 and as first-line treatment for frail and elderly patients in the NEUPSIG guideline 2015.32
Hear Professor Gunnar Wasner's commenting on Versatis®
The use of Versatis® is recommended as a first line treatment for PHN by EFNS
For more information on the use of Versatis® within your national treatment guidelines, please visit your local Versatis® website.